Globe Life (NYSE:GL) CMO Jennifer Allison Haworth Sells 10,000 Shares of Stock

Globe Life Inc. (NYSE:GL) CMO Jennifer Allison Haworth sold 10,000 shares of Globe Life stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the sale, the chief marketing officer owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This trade represents a 36.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Globe Life Stock Performance

Shares of GL opened at $144.46 on Friday. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The company’s 50 day simple moving average is $140.57 and its 200 day simple moving average is $138.44. The company has a market capitalization of $11.50 billion, a price-to-earnings ratio of 10.26 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm posted $3.14 earnings per share. The company’s revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on GL. JPMorgan Chase & Co. raised their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings downgraded shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price target on shares of Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a report on Tuesday, October 28th. Morgan Stanley restated an “overweight” rating and set a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Finally, Wells Fargo & Company cut their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Seven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and an average price target of $171.00.

Hedge Funds Weigh In On Globe Life

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after purchasing an additional 86,349 shares during the last quarter. Invesco Ltd. grew its holdings in Globe Life by 3.9% during the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after buying an additional 147,644 shares in the last quarter. Geode Capital Management LLC grew its holdings in Globe Life by 2.9% during the second quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock worth $339,875,000 after buying an additional 76,995 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Globe Life by 2.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after buying an additional 59,629 shares during the last quarter. Finally, Morgan Stanley lifted its stake in Globe Life by 7.2% during the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after acquiring an additional 125,567 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.